# Fasted Bioequivalence Study of Clopidogrel Film-coated Tablets, 75 mg in 48 Healthy, Adult Male and Female Subjects.

> **NCT05125549** · PHASE1 · COMPLETED · sponsor: **Joint Stock Company "Farmak"** · enrollment: 48 (actual)

## Conditions studied

- Pharmacokinetics

## Interventions

- **DRUG:** Сlopidogrel bisulfate film-coated tablets, 75 mg (JSC Farmak, Ukraine)
- **DRUG:** Plavix® 75 mg film-coated tablets (Sanofi Winthrop Industrie, France)

## Key facts

- **NCT ID:** NCT05125549
- **Lead sponsor:** Joint Stock Company "Farmak"
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-12
- **Primary completion:** 2018-08-27
- **Final completion:** 2018-08-27
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2021-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05125549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05125549, "Fasted Bioequivalence Study of Clopidogrel Film-coated Tablets, 75 mg in 48 Healthy, Adult Male and Female Subjects.". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05125549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*